Oura Advisor CAIHL draft report

Oura Advisor: CAIHL reassessment

September 8, 2026. Published AI-assisted draft.

Oura Advisor offers optional wellness interpretation with conversation, memory, and notification controls. The Counsel integration is a separate, optional medical-care path with consented data sharing. These documented choices were not tested in the app.

Scope and agency posture

Optional Oura Advisor wellness interpretation. Counsel medical AI and physician care are a separate, optional integration with a distinct data transfer.

Posture: Potentially agency-expanding, inside a closed vendor ecosystem.

Axis: 75/100, retained provisionally. No numerical recalibration was performed.

Sources and documented findings

• Oura's June 11 support page documents conversation history and thread deletion, selectable style and check-ins, memory deletion and full reset. It says no Advisor data collection occurs before setup, and acknowledges discrepancies between Advisor and app data. https://support.ouraring.com/hc/en-us/articles/39512345699219-Oura-Advisor

• The Counsel announcement specifies opt-in Labs participation, consented data sharing and additional physician costs. It describes optional escalation and proactive suggestions to connect, with care delivered by Counsel. An announced June 16 rollout is not hands-on confirmation of current availability. https://ouraring.com/blog/counsel-integration-oura-app/

Patient authority

Inference from the documented workflow: Members initiate questions and control memory, notification frequency and use. Proactive care suggestions create a potential referral influence, but the documented path preserves a choice to participate and escalate.

Critical capacity

Editorial assessment: Data discussion and histories can support reflection and appointment preparation. Deleting a mistaken memory is useful control but does not establish correction of advice or underlying measurements.

Informed control

Editorial assessment: The published separation of Oura wellness and Counsel medical care is more explicit than the baseline's anticipated boundary. App usability and the general model supplier remain unverified.

Assessment and limits

Patient direction remains meaningful. Update the dated claims about upcoming integration and limited conversation controls. Hardware and subscription barriers do not independently establish institutional direction.

Confidence: Moderate for documented controls.

Remaining uncertainty: Actual handoff labeling, recommendation sourcing and underlying general-model provider remain unverified

Published documentation is evidence of stated conditions, not proof of actual implementation. Unknowns did not receive automatic negative points. Funding, sponsorship, and public code do not determine agency by themselves.

Review provenance

• Reviewer/model: OpenAI Codex / GPT-6.
• Method: Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.
• Human review: Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.
• Earlier review: 2026-06-10. Historical assessment. Earlier claims are not automatically reverified by this publication.